1. Molecular aspects of estrogen receptor variants in breast cancer

   • Suzanne A. W. Fuqua
   • Douglas M. Wolf

   San Antonio Breast Cancer Symposium — plenary lecture Pages: 233 - 241

2. Phase II study of high-dose epirubicin, lonidamine, alpha 2b interferon in advanced breast cancer

   • Rosario Vincenzo Iaffaioli
   • Anna Tortoriello
   • Francesco Caponigro

   Report Pages: 243 - 248

3. Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer

   • Robin Murray
   • Paula Pitt

   Report Pages: 249 - 253

4. The biochemistry of breast cyst fluids and duct secretions

   • Otto W. Sartorius

   Report Pages: 255 - 266

5. Nonattendance in the Stockholm mammography screening trial: Relative Mortality and reasons for nonattendance

   • E. Lidbrink
   • J. Frisell
   • L. -E. Rutqvist

   Report Pages: 267 - 275

6. Increased phosphotyrosine in breast cancer tissue is associated with a worse prognosis

   • Elyse E. Lower
   • Mary Ann Miller
   • Sue Heffelfinger

   Report Pages: 277 - 282

7. The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

   • Nathalie Quénel
   • Jean Wafflart
   • Jean-Michel Coindre

   Report Pages: 283 - 291

8. Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas

   • Nicola Normanno
   • Nancy Kim
   • David S. Salomon

   Brief Communication Pages: 293 - 297